🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchBimagrumab + semaglutide — myostatin inhibitor combo for body recomp Page 4

Bimagrumab + semaglutide — myostatin inhibitor combo for body recomp

MikeFit_NJ Thu, May 14, 2026 at 9:31 AM 22 replies 751 viewsPage 4 of 5
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
May 16, 2026 at 12:57 AM#16
james_edin said:
MikeFit_NJ said: ...but the FDA says semaglutide...

This is my experience too, for whatever a second data point is worth. I had assumed I was the exception until I read this.

Last edited: May 16, 2026 at 2:57 AM
44 19FitDadDave, RunnerRach, TrialNerd_Beth and 41 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
May 16, 2026 at 6:04 AM#17

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

43 18InsuranceTom, WendyG_ATL, SaraMom3 and 40 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
May 16, 2026 at 11:11 AM#18
Dr.PathRoch said:
It helps to say which part of this you are uncertain about.

Same pattern here, and in the same order.

Last edited: May 16, 2026 at 4:11 PM
42 17MariaRD, AussieAnna, BethLabQueen and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
May 16, 2026 at 4:18 PM#19
Dr.PathRoch said:
It helps to say which part of this you are uncertain about.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

41 16mike_mealprep, NicoleRaleigh, james_edin and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 16, 2026 at 9:25 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

19 19PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 16 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register